medicine-technology-1/thrombogenics-microplasmin-phase-iii-program-progressing-according-to-schedule-4647-1/;/a><br

(Date:11/9/2009)...may be more than twice as likely to develop multip...ns who are not obese, according to a study publish...logy , the medical journal of the American Academy...omen from the Nurses, Health Study and Nurses, Hea...n answered a questionnaire about their health beha...

(Date:11/9/2009)...wire/ -- CBS Vision, the research division of CBS ...a Group company, today announced a new research pa...the CBS Television City research facility housed i... venture, which marries the capabilities of CBS Vi...ll be called Communications Lab@OMD . ,, CBS,s...

(Date:11/9/2009)...nia and elsewhere provide support for the use of m...d protecting marine habitats, according to biologi..., A recent study in the Gulf of California, for ...ehind marine reserves--the idea that offspring pro... of harvested species outside the reserve. , "It...

(Date:11/9/2009).... 9 Sutter Health, a family of doc...re service providers, is donating $255,000 to food...cal food banks will share the quarter-million-doll...ables of thousands of families across the north st...artnering with and supporting charitable programs ...

(Date:11/9/2009)... with drugs that inhibit estrogen, , , ...to treat breast cancer and osteoporosis eliminated.... , The drugs also cleared precancerous growths... of cancer in mice with precancerous lesions. ,... cancer/osteoporosis drug raloxifene were given to...

(Date:11/9/2009)...both eye conditions are age-related, researchers s...- Cataract surgery doesn,t appear to speed the pro..., according to a new study that challenges the bel... the other. , "Because both conditions are stro...lso have AMD," wrote Li Ming Dong, of Stony Brook ...

(Date:11/9/2009)... /PRNewswire-FirstCall/ - Hard To Treat Diseases (...at Novartis, a US$41 billion international healthc...N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmace...Switzerland will begin a five-year, $1 billion Chi...atically increase its investment in its China R&am...

(Date:11/9/2009)...ive Cancer Network (NCCN) has posted a draft white...adigm for near-term comparative effectiveness clin...ument introduces the NCCN Comparative Therapeutic ...mpares the risk-versus-benefit of different treatm...ice Guidelines in Oncology(TM). The paper will be ...

Mouse/Rat Anti-Canine CD3 / CD4 Dual Colour Reagent Antibody, FITC / R-Phycoerythrin Conjugated from AbD Serotec

4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)

Essential Techniques: Gel Electrophoresis: Proteins from Promega

Colloids and Interfaces with Surfactants and Polymers an Introduction. Jim Goodwin. Wiley (2004); 296 pages soft cover from Invitrogen

COULTER AcT diff2 (Recertified)

mini VIDAS - Recertified

ACE Alera

...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...